The Mission of the Office of Sciences at the TTUHSC School of Pharmacy is to coordinate the school's research needs with our state-of-the-art scientific and technical support and to promote and accelerate research grant applications and new award set-up.
The Office of Sciences is available to all faculty on each of the four TTUHSC School of Pharmacy campus sites: Amarillo, Abilene, Dallas/Fort Worth and Lubbock. Our purpose is to act as resource for the granting process, facilitate research and administer internal research programs.
Programs and Services
The Office of Sciences provides and oversees the following programs and services:
NEWSFLASH: Research Days 2014
AWARDS AND HONORS
2014 AAPS Pharmaceutical Research Outstanding Manuscript Award
||Quentin Smith, Professor in the Pharmaceutical Sciences Department and Dean of the School of Pharmacy, and Ramakrishna Samala, Kunal S. Taskar, Vinay Rudraraju, Rajendar K. Mittapalli, Helen R. Thorsheim, Julie Lockman, Brunilde Gril, Emily Hua, Diane Palmieri, Joseph W. Polli, Stephen Castellino, Stephen D. Rubin, Paul R. Lockman, and Patricia S. Steeg will be honored for the manuscript titled: Lapatinib Distribution in HER2 Overexpressing Experimental Brain Metastases of Breast Cancer. The team will be formally recognized during the Opening Session of the 2014 AAPS Annual Meeting & Exposition held at the San Diego Convention Center in San Diego, California, on November 2, 2014. READ ARTICLE
July 2014 Grant Award Highlights
Dr. Mark Lyte – DOD Office of Naval Research
Microbiology Endocrinology as a Mechanism for Governing Stress-Induced Microbiome-Gut-Brain Communication
Additional grant award notices received in July:
- Dr. Luca Cucullo – Alternatives Research & Development Foundation
- Dr. Mark Lyte – NIH R21/R33 Multi-PI Award
High Impact Publications
||Dr. Ruiwen Zhang, Professor in the Department of Pharmaceutical Sciences, and his team identified a new class of MDM2 inhibitor called SP141, which may be further developed as a therapy for pancreatic cancer. The study, “Identification of a New Class of MDM2 Inhibitor that Inhibits Growth of Orthotopic Pancreatic Tumors in Mice,” was just accepted for publishing in the journal Gastroenterology (Impact Factor 13.926). READ ARTICLE
||A team of researchers led by Dr. Xinli Liu, Assistant Professor in the Department of Pharmaceutical Sciences, describe a novel finding of the mechanism and in vivo fate of tumor targeted nanoparticles in the journal ACS Nano, a leading journal in the field of nanoscience and nanotechnology with an impact factor of 12.06. The finding supports a new concept for understanding in vivo behavior of tumor targeted cancer nanomedicine. READ ARTICLE
||A study led by Dr. Maciej Markiewski, Associate Professor in the Department of Immunotherapeutics and Biotechnology at the School of Pharmacy in Abilene, has resulted in the discovery that the blocking of the single receptor present on the surface of special type of white blood cells can reduce or even prevent metastatic spread of cancer to the lungs. The study was published online in the May 1 issue of Cancer Research (Impact Factor 8.650). READ ARTICLE
School of Pharmacy Confocal Microscope Published Imagery:
Office of Sciences
TTUHSC School of Pharmacy
1406 S. Coulter St.
Amarillo, Texas 79106
Telephone: (806) 414-9201